Dr. Patrick Yassini, M.D.
Family Medicine (Family Medicine Physician)
131 Orange Ave, #100
Coronado, CA 92118
Who else practices at this address →
San Diego County includes primary care (1% of residents) and mental health (1% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- West Virginia University School of Medicine (1995)
- Years since graduation
- 31
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 27
Licensed in California since 1997, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1995Medical school: West Virginia University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Medicine Physician primary
CA license G83939 (first issued 1997; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Sharp Memorial Hospital San Diego, CA
- Sharp Coronado Hospital and Hlthcr Ctr Coronado, CA
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 27
- Services billed
- 330
- Patients’ average age
- 79
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 43 | 19 |
| Established patient office or other outpatient visit, 30-39 minutes | 32 | 21 |
| Insertion of needle into vein (3 years or older) | 19 | 17 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Coronado, CA | 36 |
| Testosterone Cypionate Other prescribers in Coronado, CA | 17 |
| Progesterone (progesterone, micronized) Other prescribers in Coronado, CA | 15 |
| Rosuvastatin Calcium Other prescribers in Coronado, CA | 15 |
| Methadone Hcl Other prescribers in Coronado, CA | 13 |
| Trazodone Hcl Other prescribers in Coronado, CA | 13 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Coronado, CA | 11 |
| Carvedilol Er (carvedilol phosphate) | 11 |
| Tramadol Hcl Other prescribers in Coronado, CA | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 3 companies. The companies reported $442,863 in research payments for these studies, mostly to the institutions running them.
- A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age
Seqirus USA Inc · Completed · NCT06087640 - The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa.
Incyte Corporation - A phase 3 randomized observerblinded study to evaluate the safety tolerability and immunogenicity of a combined modified rna vaccine candidate against COVID19 and influenza in healthy individuals
Pfizer Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.